31st conference of the European Society of Biomaterials conference 2021

Session discussion highlights include:

Speakers: Dr Jeroen Leijten, University of Twente, Enschede, Netherlands & Dr Jeff Daelman, Business Development Manager, Innovations at Rousselot Biomedical

  • The unique properties of Gelatin for 3D bioprinting: The use of gelatin to stably incorporate nanoparticles into printable bio-inks.
  • The biocompatibility of Gelatin for use in regenerative medicines: The ability of gelatin to steer the behavior of immune cells such as macrophages towards a regenerative phenotype, or to endow bio-printed cartilage-like tissue constructs with spatially controlled mechanical properties.
  • The advantages of gelatin for use as a bio-adhesive: The chemical modification of gelatin to act as hemostatic bio-adhesive or implantable energy storage devices.

Biofabrication 2021

Unlocking the next in gelatin based therapies

Rousselot's scientific expert Dr Jeff Daelman was at the exhibitor showcase on Monday 27th at 14.45 AEST to answer questions about the benefits and importance of ultra-pure, consistent and GMP ready gelatins and modified gelatins. Discover why Rousselot’s gelatins are different and how they can accelerate clinical translation.

Biofabrication 2021

Understanding and avoiding variability: The GelMA Case

"Variability is the curse of the modeller". In this video, Dr Jeff Daelman, PhD, Rousselot Biomedical explains why.

Learn more about GelMA and how an incorrect molecular weight or degree of modification can impact your results...